A Case Report of Advanced Lung Adenocarcinoma Harboring KRAS Mutation 
Treated with Anlotinib

by Yudong SU, Zhaoting MENG, Xiaoyan XU, XinYue WANG, Ran ZUO, Yunxia HOU, Kai LI, Peng CHEN
Published 2018-05-01

Durable efficacy of anlotinib in a patient with advanced thymic squamous cell carcinoma after multiline chemotherapy and apatinib: A case report and literature review

by Ran Zuo, Cuicui Zhang, Li Lin, Zhaoting Meng, Yajie Wang, Yudong Su, Mihray Abudurazik, Ye Du, Peng Chen
Published 2020-11-01

CD31‐labeled circulating endothelial cells as predictor in anlotinib‐treated non‐small‐cell lung cancer: Analysis on ALTER‐0303 study

by Zhujun Liu, Jing Wang, Zhaoting Meng, Xinyue Wang, Cuicui Zhang, Tingting Qin, Jinliang Chen, Xiangli Jiang, Liuchun Wang, Li Lin, Xiaoling Zhang, Peng Chen, Chun Huang, Richeng Jiang, Kai Li
Published 2018-07-01